The p53-inducible cell cycle regulator 14-3-3σ exhibits tumor suppressive functions and is highly expressed in differentiating layers of the epidermis and hair follicles. 14-3-3σ/SFN/stratifin is frequently silenced in human epithelial cancers, and experimental down-regulation of 14-3-3σ expression immortalizes primary human keratinocytes. In the repeated-epilation (ER) mouse model, a heterozygous nonsense mutation of 14-3-3σ causes repeated hair-loss, hyper-proliferative epidermis, and spontaneous development of papillomas and squamous cell carcinomas in aging mice. Therefore, loss of 14-3-3σ function might contribute to epithelial tumor development. Here, we generated mice with loxP sites surrounding the single 14-3-3σ exon which allowed Cre-mediated deletion of the gene. 14-3-3σ-deficient mice are viable, but demonstrate a permanently disheveled fur. However, histological analyses of the skin did not reveal obvious defects in the hair follicles or the epidermis. Deletion of 14-3-3σ did not enhance spontaneous epidermal tumor development, whereas it increased the frequency and size of DMBA/TPA-induced papillomas. In conclusion, 14-3-3σ is dispensable for normal epidermal homeostasis but critical for suppression of chemically-induced skin carcinogenesis. In addition, these results suggest that the ER mutation of 14-3-3σ is not equivalent to loss of 14-3-3σ, but may represent a gain-of-function variant, which does not reflect the organismal function of wild-type 14-3-3σ.
IntroductIon
The mammalian epidermis undergoes continuous self-renewal to repair damaged tissue and replace aged cells. A single layer of proliferative keratinocytes at the inner base of the epidermis gives rise to non-proliferative keratinocytes which renew the suprabasal (outer) layers, until they reach the outermost layer where they terminally differentiate and are shed [1] .
In the human epidermis 14-3-3σ expression gradually increases along the axis of keratinocyte differentiation. Suppression of 14-3-3σ expression abrogates terminal keratinocyte differentiation and immortalizes human primary keratinocytes in cell culture [2, 3] . This suggests that elevated 14-3-3σ protein levels inhibit clonal expansion of cells within the epidermal basal layer and support keratinocyte differentiation.
The p63 protein is a master regulator of epidermal morphogenesis and is exclusively expressed in the basal cell layer. p63-null mice lack suprabasal layers and do not express differentiation markers [4] . ∆Np63α, an alternative p63 splice variant, transcriptionally represses 14-3-3σ expression [5] . Thus, p63 and 14-3-3σ exercise opposite functions in the epidermis. In line with this scenario, it Priority Research Paper has been reported that 14-3-3σ binds to ∆Np63α upon DNA damage and sequesters ∆Np63α to the cytoplasm to facilitate its proteasomal degradation [6] . Thereby, an elevated 14-3-3σ expression could prevent expansion of the basal keratinocyte layer.
In addition, many studies have demonstrated that 14-3-3σ expression is deregulated or lost in several types of human epithelial cancers [7, 8] . Silencing of the 14-3-3σ gene by CpG-methylation also frequently occurs in breast cancer [9] . Hence, loss of 14-3-3σ could be a necessary step for the initiation and/or progression of epithelial tumorigenesis.
14-3-3σ has been characterized as a p53-target genes that is sufficient and necessary to mediate a G 2 / M-arrest after DNA damage [10, 11] . 14-3-3σ proteins only form homodimers and have a distinct repertoire of ligand interactions when compared to the six other 14-3-3 isoforms expressed in human and murine cells [12, 13] . 14-3-3σ dimers bind to a large number of ligands via phosphorylated serine/threonine residues and thereby presumably affect a plethora of cellular processes [14] . Numerous studies based on cellular analyses have implicated 14-3-3σ in the regulation of diverse processes, such as cell cycle progression, signaling, differentiation, apoptosis and metabolism [7, [15] [16] [17] . However, relatively few studies of the organismal function and relevance of 14-3-3σ employing genetically engineered mouse models have been reported. By studying a mammary epithelial-specific 14-3-3σ knock-out mouse it was shown that 14-3-3σ-deficient mammary epithelial cells lose their polarity and show increased proliferation [18] . Amplification and elevated expression of the erbB2 protooncogene is associated with poor outcome in patients with breast cancer [19] . It has been shown that the Cremediated deletion of 14-3-3σ in an erbB2-driven breast cancer mouse model enhances tumor initiation and metastases [20] . Additionally, ectopic 14-3-3σ expression reduces the metastatic capacity of a human breast cancer cell line in a xenograft mouse model [21] . Therefore, 14-3-3σ shows tumor suppressive capacities in vivo.
The repeated epilation (ER) mouse model has been used multiple times for studying the role of 14-3-3σ in the epidermis. ER mutant mice harbor a single nucleotide insertion in the 14-3-3σ gene causing a frame shift which leads to the expression of a C-terminally truncated 14-3-3σ protein that lacks the nuclear export signal and several phosphopeptide-binding residues [22, 23] . Homozygous ER mutant mice (ER/ER) die at birth as a result of respiratory stress [22] [23] [24] : The oral cavity is fused, limbs and tail are shortened, defined digits and nails are lacking. Their epidermis is strongly hyper-proliferative and thickened accompanied with failures in terminal differentiation. The hair follicles are underdeveloped and sparse. Heterozygous ER mutant mice (+/ER) are viable. However, at postnatal day 7 they display a hyperproliferative epidermis, however not as pronounced as observed in ER/ER mutant mice at embryonic day E18.5. Furthermore, +/ER mutant mice show defects in hair shaft differentiation, resulting in destruction of the hair shaft and a cyclic hair loss [25] . Studies analyzing this hair defect showed that the heterozygous ER-mutation in 14-3-3σ specifically affects the club hair retention [26] and causes severe defects in hair shaft differentiation during morphogenesis and abnormal cycling of the hair follicle stem cells in the bulge [25] . In addition, heterozygous ER-mice show an extensive hyper-proliferation of the epidermis followed by the development of multiple papillomas and squamous cell carcinoma at the age of 6 month [27] . ER-mice display increased levels of p63 in the epidermal suprabasal layers, suggesting that truncated 14-3-3σ fails to block the transcription of TP63 which may contribute to hyper-proliferation of the epidermis [28] . In addition, Yap1, an essential factor of the Hippo pathway controlling organ size and tissue homeostasis [29] , is expressed in the epidermal suprabasal layers of ER-mice [30] . In keratinocytes derived from ER mice truncated 14-3-3σ fails to bind and sequester Yap1 in the cytoplasm, suggesting that 14-3-3σ inhibits Yap1-dependent gene expression to control epidermal proliferation and differentiation.
To date the in vivo role of 14-3-3σ expression in epidermal homeostasis and tumorigenesis has been mainly inferred from results obtained with ER-mice. However, truncation of the 14-3-3σ protein in ER-mice may not be equivalent to deletion and therefore complete inactivation of 14-3-3σ function.
In this study we provide evidence that the ER phenotype may rather result from a gain of function mutation since we determined that 14-3-3σ deficiency does not affect homeostasis of normal epidermal tissues and does not result in perinatal lethality seen in ER/ER mice. Nonetheless, loss of 14-3-3σ sensitizes mice to chemically-induced skin carcinogenesis. Therefore, 14-3-3σ may indeed represent a mediator of tumor suppression in the skin.
results And dIscussIon

14-3-3σ-deficient mice display disorganized hair but lack obvious epidermal defects
In order to analyze whether the reported phenotypes of ER-mice are caused by the expression of the truncated 14-3-3σ protein or are due to 14-3-3σ loss of function, we generated mice with a floxed 14-3-3σ allele and inactivated the 14-3-3σ gene in the germ-line by crossing these with deleter-Cre mice (see also Supplemental Figure S1 ). By further back-crossing we obtained 14-3-3σ-deficient mice with an FVB background. FVB mice are prone to develop tumors of the skin when www.impactjournals.com/oncotarget subjected to chemical carcinogenesis [31] . Mice with heterozygous (14-3-3σ
) and homozygous (14-3-3σ -/-) deletion of 14-3-3σ were viable, fertile and born at the normal Mendelian ratio, had a normal life-span and did not display an increase in tumor formation (data not shown). 14-3-3σ +/-mice were indistinguishable from their wild-type littermates. However, 14-3-3σ -/-mice showed a disorganized fur beginning around postnatal day 17 ( Figure 1) . Nonetheless, the histological analysis of skin from postnatal day 17 animals did not reveal obvious alterations in hair follicle density or hair shaft shape (Figure 2 ). Immunohistochemical detection of Loricrin indicated no difference in epidermal thickness either. Ki-67 staining did not reveal differences in proliferation of keratinocytes between the genotypes. Therefore, 14-3-3σ -/-mice and 14-3-3σ +/ER mutant mice have at least one phenotype in common: a disorganized fur onwards from approximately 2 weeks after birth. However, other phenotypes characteristic for 14-3-3σ +/ER mice were not observed in 14-3-3σ-deficient mice: the frequency of Ki-67-positive hair follicle matrix cells (Figure 2A ) or basal epidermal cells ( Figure 2B ) was unchanged. Additionally, the number of hair follicles and the epidermal thickness showed no differences in 14-3-3σ
-/-tissues ( Figure 2 ). Similar results were obtained after tissue specific 14-3-3σ knockout in the epidermis of mice with a the C57BL/6J background (Supplementary Figure S2A) . This suggested that the epidermal hyper-proliferation observed in 14-3-3σ +/ER mice is caused by the expression of the truncated 14-3-3σ protein, which acquired additional functions and presumably an altered ligand specificity, and not by the mere loss of 14-3-3σ function. Notably, p63 and YAP1 have been shown to functionally interact with the ER mutant of 14-3-3σ in murine epidermis [28, 30] . However, we could not detect an effect of 14-3-3σ loss on the localization and expression level of p63 (Supplemental Figure 2B ). In addition, we were unable to detect a functional or direct interaction or colocalization of 14-3-3σ with YAP1 in cells ex vivo (data not shown). Also YAP1 expression and localization in chemically induced skin papillomas was not affected by deletion of 14-3-3σ in mice (data not shown). The expression of a truncated ER 14-3-3σ mutant may therefore indirectly promote the deregulation of p63 and YAP1, whereas complete loss of 14-3-3σ function does not affect the function and expression of p63 or YAP1. This divergence could, at least in part, explain the phenotypic differences between the ER mice and 14-3-3σ knock-out mice.
Unchanged frequency of spontaneous epidermal tumors in 14-3-3σ deficient mice
To exclude the possibility that mice lacking 14-3-3σ exhibit an attenuated epidermal hyper-proliferation phenotype similar to that of 14-3-3σ +/ER mice, we analyzed the long-term consequences of 14-3-3σ deficiency in mice.
14-3-3σ
+/+ ,
+/-and 14-3-3σ -/-(40 mice / genotype) mice were maintained for a prolonged time period (up to 32 months) and were inspected twice a week for the presence of neoplastic lesions or other pathologies. Mice with tumors larger than 2 cm in diameter or with other signs of illness were euthanized. Dead mice were analyzed by necropsy. Tumor burden of dead mice was recorded Figure 3A, 3B) . No significant difference in survival between wild-type, heterozygous and knockout 14-3-3σ mice was found. In addition, 14-3-3σ knockout mice did not show a significantly increased risk of spontaneous tumor development ( Figure 3A, 3B) . Furthermore, the tumor burden was independent from the genotype ( Figure  3A) . These results show that 14-3-3σ deficiency is not sufficient to initiate spontaneous skin carcinogenesis. Therefore, the development of multiple papillomas and squamous cell carcinomas observed in 14-3-3σ +/ER mice [27] is presumably not caused by the loss of 14-3-3σ function but rather by the expression of a truncated 14-3-3σ protein, which presumably acquired additional, nonphysiologic properties.
14-3-3σ deficiency increases number and size of DMBA/TPA induced papillomata
The 14-3-3σ gene is frequently silenced in basal cell and squamous cell carcinoma [8, 32, 33] . Nevertheless, the pathophysiological relevance of 14-3-3σ inactivation for epithelial skin cancer formation is largely unknown. In order to study the effect of 14-3-3σ inactivation on the onset, frequency and progression of chemically-induced papillomas of the skin, which ultimately progress to squamous cell carcinomas (SCC), we employed a well-established two-stage model of chemical skin-carcinogenesis which is based on DMBA/ TPA treatments [34] . The back skin of male wild-type and 14-3-3σ knockout mice (7 to 9 weeks old) was treated in the pause phase of the hair cycle with a single dose of 7.12-dimethylbenz(a)anthracene (DMBA) for tumor initiation ( Figure 4A ). Two weeks later, both groups were treated twice a week with 12-O-tetradecanoylphorbol-13 acetate (TPA) for a total period of 20 weeks to achieve tumor promotion. The time points of tumor occurrence, number and size were quantified throughout the complete treatment period (Figure 4C-4F ). After 20 weeks the back skin was resected ( Figure 4B ) and the number (4C) and size (4D) of tumors present in these specimen was determined. Subsequently, tumors were analyzed histologically ( Figure  5 ). ~7 weeks after the first TPA administration the first skin tumors (≥1 mm diameter) occurred in both groups ( Figure 4E ). Over the subsequent 13 weeks of tumor promotion, the number of mice with tumors ( Figure 4E ) and the number of tumors per mouse ( Figure 4F ) increased significantly faster in 14-3-3σ -deficient mice. By the end of the TPA treatments, 100% of the 14-3-3σ-deficient and 89% of the wild-type mice had developed numerous tumors. 60% of the 14-3-3σ deficient and only 11% of the wild-type mice had 16 or more tumors ( Figure 4C ). Counting of tumors with an area of ≥15mm 2 revealed that 14-3-3σ wild-type mice developed on average 2.8, whereas 14-3-3σ knock-out mice displayed 5.5 papilloma of this size ( Figure 4D ). Taken together, 14-3-3σ-deficient mice developed 1.8-fold more papillomas per mouse in total and 1.98-fold more larger tumors (≥15mm 2 ) per mouse than wild-type mice ( Figure 4F, 4D) . Further examination revealed that all induced tumors from wildtype and 14-3-3σ knock-out mice projected outwardly, with a cauliflower-like shape, which is a characteristic of benign papillomas (see example in Figure 5 ). Next we obtained tissues sections containing tumors of different sizes from wild-type and 14-3-3σ-deficient mice and analyzed them microscopically after haematoxilin/eosin staining and by immunohistochemistry ( Figure 5 ). Like we already had deduced from the external examination of the tumors (Figure 4B) , inspection of the histological sections confirmed a tumor growth directed towards the outer side of the epidermis ( Figure 5 ). The tumors resemble the architecture of normal skin with a basal layer, stratified squamous epithelium and an outer keratinized layer ( Figure 5A ). No invasion was observed ( Figure 5B ). Taken together our results show that 14-3-3σ deficiency significantly increases the number and size of DMBA/ TPA-induced papillomas. Thus, 14-3-3σ fulfills a tumor suppressive function in vivo, which presumably prevents the initiation and growth of epidermal tumors. This is in line with the timing of epigenetic inactivation of 14-3-3σ in tumors, which has been described to occur in the early phases of tumor progression [35] .
MAterIAls And Methods
Generation and handling of mice
The detailed description of the generation of 14-3-3σ deficient mice can be found in supplementary material and methods ( Figure S1 ). 14-3-3σ -/-mice were transferred into an FVB background by backcrossing for at least 6 generations with FVB wild-type mice. For the experiments, FVB littermates of the genotypes 14-3-3σ
14-3-3σ
+/-and 14-3-3σ -/-were generated by intercrossing of FVB 14-3-3σ +/-mice. All mice were maintained in the animal facility at the Pathology Institute of the LudwigMaximilians-University Munich in individually ventilated cages (IVC). All animal experiments were approved by the Regierung von Oberbayern (AZ: 55.2-1-54-2532-11-13).
Genotyping PCR
Genomic DNA was obtained by overnight digest of ear punches in lysis buffer (50 mM KCl, 1.5 mM MgCl 2 , 10 mM Tris pH8.5, 0.01% gelatin, 0.45% NP40, 0.45% Tween 20, 100 µg/ml proteinase K). PCR was performed for 35 cycles with an annealing temperature of 65°C. Primers for the detection of the 14-3-3σ wild-type and floxed alleles (forward: 5'-CAC TAC CGT GGT CTT CCC TAA CTT GAT G-3'; reverse: 5'-TCC CAG GAA GCA GAT GGG ATT TCT GTC C-3') and the 14-3-3σ knock-out allele (reverse: 5'-AGG CAC TAT GCC CCT GCC TCA GAT-3') were added in the same ratio to the reaction mix and PCR products were resolved on 2% agarose or 8% polyacrylamide gels. The PCR-products were 106 bp (wild-type allele), 159 bp (floxed allele), and 183 bp (14-3-3σ knock-out allele).
Determination of hair follicle numbers and epidermal thickness
Dorsal skin from male 14-3-3σ +/+ and 14-3-3σ -/-FVB littermates was dissected, fixed in 4% formalin, paraffin embedded, vertically sectioned at 5 µm distances, stained with haematoxilin and eosin (H&E), mounted and analyzed by light microscopy. Hair follicles were counted over an epidermis length of 1 mm from 3 individuals per genotype. In addition, the epidermal thickness was measured at 3 randomly chosen positions of the epidermis of 350 µm length using the AxioVison Rel4.8 software.
Average numbers, standard deviation and significance were calculated using a Student's test (two-sided; n = 3).
Survival probability
40 mice (20 male, 20 female) per genotype (14-3-3σ
) with a FVB background were maintained and monitored over a period of more than 2 years. Moribund mice were euthanized and skin sections were analyzed immunohistochemically. Tumor burden [No = 0, Yes = 1] and age at death [in days] was documented. Survival probability was calculated according to KaplanMeier using GraphPad Prism5 software. Additionally, the percentage of mice with tumors was calculated.
Chemically-induced skin carcinogenesis
The back skin of male 14-3-3σ +/+ (n = 9) and 14-3-3σ -/-FVB (n = 10) littermates (7-9 weeks of age) was shaved 2 days prior to tumor initiation. Tumors were initiated with a single topical application of DMBA (Sigma-Aldrich, Munich, Germany, order no. 40567, 100 nmol in 50 µl methanol) to the back skins of the mice. Two weeks later, tumor promotion was achieved by topical application of TPA (Sigma-Aldrich, Munich, Germany, order no. P1585, 13.6 nmol in 200 µl acetone) twice weekly for 20 weeks. Tumor incidence (percentage of tumor-bearing mice) and multiplicity (papillomas per mouse) were recorded twice weekly throughout the experiment. Pictures of dissected back skin were taken and used to determine the sizes of papillomas [mm 2 ] with the ImageJ software.
Immunohistochemistry
Tissues were fixed in 4% formalin and embedded in paraffin. 5 µm sections were prepared, deparaffinized in xylene and rehydrated in serial ethanol dilutions. Antigen retrieval was carried out by boiling in DAKO citrate buffer (pH 6.0) twice for 15 minutes in a microwave oven at 750 Watts. After quenching endogenous peroxidase activity by 10 min. exposure to 7.5% H 2 O 2 solution, tissue sections were blocked in either 10% goat or rabbit serum, or 10% BSA for 30 min. at room temperature depending on the origin of the primary antibody. Primary antibodies were used at 1:20 dilution for anti-14-3-3σ (C-18, goat polyclonal anti-mouse, Santa Cruz), 1:500 for anti-Ki67 (D3B5, rabbit monoclonal anti-mouse, Cell Signaling), 1:500 for anti-Loricrin (AF62, rabbit polyclonal antimouse, Covance) and 1:100 for anti-p63 (4A4, Dako, supplementary data). Biotinylated secondary antibodies and streptavidin/HRP complexes were used according to the provided manual (Vectastain kit, Vector Labs). Sections were treated with DAB chromogenic substrate (DAKO), counterstained with haematoxilin and mounted in xylene-based mounting medium.
Abbreviations
ER, repeated epilation; DMBA, 7.12-dimethylbenz(a)anthracene; TPA, 12-O-tetradecanoylphorbol-13 acetate
